- Home
- FDMT vs XRN Comparison
FDMT vs XRN Comparison
Compare FDMT & XRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$8.71
N/A
Current Price
$35.86
Company Overview
Basic Information| Metric | FDMT | XRN |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 513.6M | 464.3M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | FDMT | XRN |
|---|---|---|
| Price | $8.71 | $35.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $34.13 | N/A |
| AVG Volume (30 Days) | ★ 725.8K | 184.8K |
| Earning Date | 04-13-2026 | N/A |
| Dividend Yield | N/A | ★ 8.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,000.00 | N/A |
| Revenue This Year | $21,227.03 | $3.38 |
| Revenue Next Year | $161.87 | $3.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $33.82 |
| 52 Week High | $12.34 | $37.46 |
Technical Indicators
Market Signals| Indicator | FDMT | XRN |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 50.48 |
| Support Level | $8.11 | N/A |
| Resistance Level | $8.80 | $37.46 |
| Average True Range (ATR) | 0.57 | 1.44 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 20.96 | 53.84 |
Price Performance
Historical Comparison FDMT
XRN
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.